Azole-Based Compounds That Are Active against <i>Candida</i> Biofilm: In Vitro<i>,</i> In Vivo and In Silico Studies

Fungal pathogens, including <i>Candida</i> spp., <i>Aspergillus</i> spp. and dermatophytes, cause more than a billion human infections every year. A large library of imidazole- and triazole-based compounds were in vitro screened for their antifungal activity against <i>...

Full description

Saved in:
Bibliographic Details
Main Authors: Simone Carradori (Author), Alessandra Ammazzalorso (Author), Barbara De Filippis (Author), Ahmet Fatih Şahin (Author), Atilla Akdemir (Author), Anastasia Orekhova (Author), Graziana Bonincontro (Author), Giovanna Simonetti (Author)
Format: Book
Published: MDPI AG, 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1fcde60dbc564825a07008e57a0eee7f
042 |a dc 
100 1 0 |a Simone Carradori  |e author 
700 1 0 |a Alessandra Ammazzalorso  |e author 
700 1 0 |a Barbara De Filippis  |e author 
700 1 0 |a Ahmet Fatih Şahin  |e author 
700 1 0 |a Atilla Akdemir  |e author 
700 1 0 |a Anastasia Orekhova  |e author 
700 1 0 |a Graziana Bonincontro  |e author 
700 1 0 |a Giovanna Simonetti  |e author 
245 0 0 |a Azole-Based Compounds That Are Active against <i>Candida</i> Biofilm: In Vitro<i>,</i> In Vivo and In Silico Studies 
260 |b MDPI AG,   |c 2022-10-01T00:00:00Z. 
500 |a 10.3390/antibiotics11101375 
500 |a 2079-6382 
520 |a Fungal pathogens, including <i>Candida</i> spp., <i>Aspergillus</i> spp. and dermatophytes, cause more than a billion human infections every year. A large library of imidazole- and triazole-based compounds were in vitro screened for their antifungal activity against <i>C. albicans</i>, <i>C. glabrata</i>, <i>C. krusei</i>, <i>A. fumigatus</i> and dermatophytes, such as <i>Microsporum gypseum, Trichophyton rubrum</i> and <i>Trichophyton mentagrophytes</i>. The imidazole carbamate <b>12</b> emerged as the most active compound, showing a valuable antifungal activity against <i>C. glabrata</i> (MIC 1-16 μg/mL) and <i>C. krusei</i> (MIC 4-24 μg/mL). No activity against <i>A. fumigatus</i> or the dermatophytes was observed among all the tested compounds. The compound <b>12</b> inhibited the formation of <i>C.</i> <i>albicans</i>, <i>C.</i> <i>glabrata</i> and <i>C.</i> <i>krusei</i> biofilms and reduced the mature <i>Candida</i> biofilm. In the <i>Galleria mellonella</i> larvae, <b>12</b> showed a significant reduction in the <i>Candida</i> infection, together with a lack of toxicity at the concentration used to activate its antifungal activity. Moreover, the in silico prediction of the putative targets revealed that the concurrent presence of the imidazole core, the carbamate and the <i>p</i>-chlorophenyl is important for providing a strong affinity for lanosterol 14α-demethylase (CgCYP51a1) and the fungal carbonic anhydrase (CgNce103), the <i>S</i>-enantiomer being more productive in these interactions. 
546 |a EN 
690 |a azoles 
690 |a antifungal agents 
690 |a antibiofilm 
690 |a <i>Candida</i> 
690 |a dermatophytes 
690 |a <i>Aspergillus</i> 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 11, Iss 10, p 1375 (2022) 
787 0 |n https://www.mdpi.com/2079-6382/11/10/1375 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/1fcde60dbc564825a07008e57a0eee7f  |z Connect to this object online.